Haemonetics CEO to Discuss Innovations in Healthcare at 2026 Conference

Haemonetics at the 2026 Healthcare Conference

On May 5, 2026, Haemonetics Corporation (NYSE: HAE) announced its upcoming presentation at the Bank of America 2026 Healthcare Conference. The event is set to take place on Tuesday, May 12, 2026, starting at 8:00 AM PT. Chris Simon, the President and CEO of Haemonetics, will participate in a fireside chat that aims to engage investors and stakeholders in a discussion about the company’s innovative solutions in the healthcare sector.

Accessing the Event

For those interested in attending, a live webcast of the fireside chat will be available through Haemonetics' Investor Relations website. Additionally, a replay of the session will be accessible within 24 hours following the event. This replay will remain on the Investor Relations site for a full year, making it convenient for those who couldn't attend live.

About Haemonetics

Haemonetics is a leading global medical technology firm that focuses on enhancing healthcare quality, effectiveness, and efficiency. The company is deeply committed to addressing pressing medical needs through innovative solutions that elevate patient care standards.

Among its offerings are technologies designed specifically for hospitals that help improve patient outcomes, comprehensive plasma collection systems that optimize operations for plasma centers, and products that aid blood centers in collecting critical blood components. These innovations showcase Haemonetics' dedication to advancing healthcare technology and standards, ultimately benefiting both healthcare providers and patients alike.

Why It Matters

Simon’s participation in this event is pivotal as it represents the company’s ongoing efforts to inform and engage with investors regarding its mission and future directions within the healthcare landscape. By sharing insights at a major conference, Haemonetics emphasizes its role as a thought leader in medical technology while also underlining the importance of collaboration and support from investors in advancing healthcare solutions.

Conclusion

The Bank of America 2026 Healthcare Conference presents a significant opportunity for Haemonetics to highlight its innovations and the impact they have on health care. For those within the industry or interested in healthcare advancements, this event should not be missed. Tune in to hear about how Haemonetics continues to shape the future of healthcare through its innovations and commitment to quality.

To learn more about Haemonetics and its extensive portfolio, visit www.haemonetics.com.